首页> 美国卫生研究院文献>other >Microgels produced using microfiuidic on-chip polymer blending for controlled released of VEGF encoding lentivectors
【2h】

Microgels produced using microfiuidic on-chip polymer blending for controlled released of VEGF encoding lentivectors

机译:使用微流体芯片上聚合物共混物生产的微凝胶可控释放VEGF编码慢载体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alginate hydrogels are widely used as delivery vehicles due to their ability to encapsulate and release a wide range of cargos in a gentle and biocompatible manner. The release of encapsulated therapeutic cargos can be promoted or stunted by adjusting the hydrogel physiochemical properties. However, the release from such systems is often skewed towards burst-release or lengthy retention. To address this, we hypothesized that the overall magnitude of burst release could be adjusted by combining microgels with distinct properties and release behavior. Microgel suspensions were generated using a process we have termed on-chip polymer blending to yield composite suspensions of a range of microgel formulations. In this manner, we studied how alginate percentage and degradation relate to the release of lentivectors. Whereas changes in alginate percentage had a minimal impact on lentivector release, microgel degradation led to a 3-fold increase, and near complete release, over 10 days. Furthermore, by controlling the amount of degradable alginate present within microgels the relative rate of release can be adjusted. A degradable formulation of microgels was used to deliver VEGF-encoding lentivectors in the chick chorioallantoic membrane assay and yielded a proangiogenic response in comparison to the same lentivectors delivered in suspension. The utility of blended microgel suspensions may provide an especially appealing platform for the delivery of lentivectors or similarly sized therapeutics.
机译:海藻酸盐水凝胶由于能够以温和且生物相容的方式封装和释放各种货物的能力而被广泛用作递送载体。可以通过调节水凝胶的理化特性来促进或阻止封装的治疗性货物的释放。但是,从此类系统中释放通常倾向于突发释放或长时间保留。为了解决这个问题,我们假设可以通过结合具有不同特性和释放行为的微凝胶来调节整体释放的幅度。使用我们称为片上聚合物共混的方法生成微凝胶悬浮液,以产生一系列微凝胶制剂的复合悬浮液。通过这种方式,我们研究了藻酸盐百分比和降解与慢病毒载体释放的关系。尽管藻酸盐百分比的变化对慢载体的释放影响最小,但微凝胶降解导致在10天内增加了3倍,并几乎完全释放。此外,通过控制微凝胶内存在的可降解藻酸盐的量,可以调节相对释放速率。可降解的微凝胶制剂用于在鸡绒膜尿囊膜测定中递送编码VEGF的慢病毒载体,并且与悬浮液中递送的相同慢病毒载体相比,产生促血管生成应答。混合的微凝胶悬浮液的实用性可以为递送慢载体或类似尺寸的治疗剂提供特别吸引人的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号